Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP

References

• Lux MP, Fasching PA, Beckmann MW. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med. 2006;84(1):16–28.
   PubMed Web of Science ®Google Scholar
• Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–1333.
   PubMed Web of Science ®Google Scholar
• Nelson HD, Pappas M, Zakher B, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-Related cancer in women: a systematic review to update the U.S. Preventive services task force recommendation. Ann Intern Med. 2014;160(4):255–266.
   PubMed Web of Science ®Google Scholar
• Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol. 2011;121(1):163–168.
   PubMed Web of Science ®Google Scholar
• Cohen JV, Chiel L, Boghossian L, et al. Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Fam Cancer. 2012;11(1):69–75.
   PubMed Web of Science ®Google Scholar
• Vermeulen RFM, Beurden MV, Korse CM, et al. Impact of risk-reducing salpingo-oophorectomy in premenopausal women. Climacteric. 2017;20(3):212–221.
   PubMed Web of Science ®Google Scholar
• van der Schouw YT, van der Graaf Y, Steyerberg EW, et al. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714–718.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association. Circulation. 2020;142(25):e506–e32.
   PubMed Web of Science ®Google Scholar
• Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–2373.
   PubMed Web of Science ®Google Scholar
• Tuna V, Alkiş I, Safiye AS, et al. Variations in blood lipid profile, thrombotic system, arterial elasticity and psychosexual parameters in the cases of surgical and natural menopause. Aust N Z J Obstet Gynaecol. 2010;50(2):194–199.
   PubMed Web of Science ®Google Scholar
• Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al. Vasomotor symptoms and lipid profiles in women transitioning through menopause. Obstet Gynecol. 2012;119(4):753–761.
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.
   PubMed Web of Science ®Google Scholar
• Michelsen TM, Pripp AH, Tonstad S, et al. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer. 2009;45(1):82–89.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–1428.
   PubMed Web of Science ®Google Scholar
• Robinson JG, Wang S, Smith BJ, et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53(4):316–322.
   PubMed Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003;107(3):499–511.
   PubMed Web of Science ®Google Scholar
• Vermeulen RFM, Beurden MV, Kieffer JM, et al. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: a prospective study. Eur J Cancer. 2017;84:159–167.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, et al. Hot flashes and subclinical cardiovascular disease: findings from the study of women’s health across the nation heart study. Circulation. 2008;118(12):1234–1240.
   PubMed Web of Science ®Google Scholar
• Pines A. Vasomotor symptoms and cardiovascular disease risk. Climacteric. 2011;14(5):535–536.
   PubMed Web of Science ®Google Scholar
• Michelsen TM, Tonstad S, Pripp AH, et al. Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer. Int J Gynecol Cancer. 2010;20(2):233–239.
   PubMed Web of Science ®Google Scholar
• Arts-de Jong M, Maas AH, Massuger LF, et al. BRCA1/2 mutation carriers are potentially at higher cardiovascular risk. Crit Rev Oncol Hematol. 2014;91(2):159–171.
   PubMed Web of Science ®Google Scholar
• Heineman MJ. Obstertrie & gynaecologie de voortplanting van de mens. Reed Business. 2012:7.
   Google Scholar
• Hunter MS, Liao KL. A psychological analysis of menopausal hot flushes. Br J Clin Psychol. 1995;34(4):589–599.
   PubMedGoogle Scholar
• Cm B. Cholesterol: concentration, ratio and particle number: Saunders Elsevier; 2020. Available from: https://www.clinicalkey.com.
   Google Scholar
• (NBOCC) NBAOCC. Recommendations for management of women at high risk of ovarian cancer. 2011.
   Google Scholar
• Harmsen MG, Steenbeek MP, Hoogerbrugge N, et al. A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: development process and pilot testing. Health Expect. 2018;21(3):659–667.
   PubMed Web of Science ®Google Scholar
• Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Statist Med. 2000;19(13):1793–1819.
   PubMed Web of Science ®Google Scholar
• G S. Estimating the dimension of a model. 1978:461–464.
   Google Scholar
• H A. Information theory and an extension of the maximum likeihood principle. In: Petrov BN, Caski F, editors Proceedings of the second international symposium on information theory budapest. Budapest: Akademiai Kiado; 1973. p. 267–281.
   Google Scholar
• Singer JW. Applied longitidunal data analysis: modeling change and event occurrence. New York: oxford University Press. 2003.
   Google Scholar
• Cohen. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum. 1988.
   Google Scholar
• El Khoudary SR, Wang L, Brooks MM, et al. Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression. J Clin Lipidol. 2016;10(4):962–969.
   PubMed Web of Science ®Google Scholar
• Li Z, McNamara JR, Fruchart JC, et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res. 1996;37(9):1886–1896.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Chen X, Nasr AN, et al. HDL (High-Density lipoprotein) subclasses, lipid content, and function trajectories across the menopause transition: SWAN-HDL study. Arterioscler Thromb Vasc Biol. 2021;41(2):951–961.
   PubMed Web of Science ®Google Scholar
• Michelsen TM, Dorum A, Trope CG, et al. Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer. Int J Gynecol Cancer. 2009;19(6):1029–1036.
   PubMed Web of Science ®Google Scholar
• Ambikairajah A, Walsh E, Tabatabaei-Jafari H, et al. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol. 2019;221(5):393–409 e50.
   PubMed Web of Science ®Google Scholar
• Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015;72:1–75.
   PubMed Web of Science ®Google Scholar
• Do KA, Green A, Guthrie JR, et al. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol. 2000;151(6):584–593.
   PubMed Web of Science ®Google Scholar
• Sari N, Engin-Ustun Y, Kiyak Caglayan E, et al. Evaluation of cardiovascular disease risk in women with surgically induced menopause. Gynecol Endocrinol. 2016;32(6):498–501.
   PubMed Web of Science ®Google Scholar
• Shelley JM, Green A, Smith AM, et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol. 1998;8(1):39–45.
   PubMed Web of Science ®Google Scholar
• Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol. 2005;23(28):6890–6898.
   PubMed Web of Science ®Google Scholar
• Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–515.
   PubMed Web of Science ®Google Scholar
• Parikh NI, Jeppson RP, Berger JS, et al. Reproductive risk factors and coronary heart disease in the women’s health initiative observational study. Circulation. 2016;133(22):2149–2158.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the european atherosclerosis society (EAS) and european federation of clinical chemistry and laboratory medicine (EFLM). Eur Heart J. 2016;37(25):1944–1958.
   PubMed Web of Science ®Google Scholar
• Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, et al. Long-Term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: protocol for a nationwide cross-sectional study with prospective Follow-Up (HARMOny study). JMIR Res Protoc. 2021;10(1):e24414.
   PubMed Web of Science ®Google Scholar